SCM
ENTA icon

Stonepine Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Stonepine Capital Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-100,000
Closed -$1.58M – 88
2025
Q4 		$1.58M Sell
100,000
-205,000
-67% -$2.6M 1.15% 27
2025
Q3 		$3.65M Sell
305,000
-299,066
-50% -$2.39M 2.97% 9
2025
Q2 		$4.57M Buy
604,066
+13,324
+2% +$80.1K 4.48% 7
2025
Q1 		$3.26M Buy
590,742
+258,842
+78% +$1.6M 3.17% 9
2024
Q4 		$1.91M Buy
+331,900
New +$3.18M 1.54% 20
2022
Q2 		– Sell
-119,972
Closed -$8.54M – 27
2022
Q1 		$8.54M Buy
+119,972
New +$7.81M 3.54% 11
2019
Q4 		– Sell
-129,867
Closed -$7.8M – 26
2019
Q3 		$7.8M Buy
129,867
+64,383
+98% +$4.78M 7.57% 4
2019
Q2 		$5.53M Buy
65,484
+4,644
+8% +$418K 3.8% 10
2019
Q1 		$5.81M Buy
+60,840
New +$5.46M 3.34% 12
2018
Q1 		– Sell
-218,434
Closed -$12.8M – 33
2017
Q4 		$12.8M Sell
218,434
-171,566
-44% -$8.59M 7.68% 5
2017
Q3 		$18.3M Sell
390,000
-102,265
-21% -$4.11M 10.76% 2
2017
Q2 		$17.7M Buy
492,265
+307,166
+166% +$9.82M 9.56% 2
2017
Q1 		$5.7M Sell
185,099
-46,814
-20% -$1.46M 3.21% 11
2016
Q4 		$7.77M Buy
+231,913
New +$6.65M 4.63% 9
2016
Q1 		– Sell
-71,147
Closed -$2.35M – 20
2015
Q4 		$2.35M Buy
+71,147
New +$2.32M 2.75% 10

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SSC
Spruce Street Capital New York $510M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Stonepine Capital Management's ENTA Position: Q1 2026 in Review

Stonepine Capital Management sold out of Enanta Pharmaceuticals (ENTA) in Q1 2026, closing a stake of 100,000 shares — an estimated $1.58M sold.

Stonepine Capital Management first reported a position in ENTA in Q4 2015 and held it in 15 quarters. The position peaked at $18.3M in Q3 2017. 133 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Stonepine Capital Management reported no remaining Enanta Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Stonepine Capital Management sold 100,000 Enanta Pharmaceuticals shares in Q1 2026, an estimated $1.58M.
  • Stonepine Capital Management first reported a position in Enanta Pharmaceuticals in Q4 2015 and held it in 15 quarters.
  • Stonepine Capital Management's Enanta Pharmaceuticals position peaked at $18.3M in Q3 2017.
  • 133 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Stonepine Capital Management's 13F filing for Q1 2026, filed 14 May 2026.